The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca‘s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble…

Read more »

The post U.S. Secures 300 Million Doses of Potential COVID-19 Vaccine appeared first on Hamodia.

In related news:

  1. U.K.’s COVID-19 Study Aims to Vaccinate More Than 10,000
  2. Swiss Agency Approves Trial for Ebola Vaccine
  3. Fearing Shortages, EU May Deploy Emergency Funds in COVID-19 Vaccine Race
  4. Pfizer, BioNTech to Codevelop Potential Coronavirus Vaccine
  5. EU Agency: Coronavirus Vaccine Possible in About a Year